Optimal defaults grocery shopping to promote healthy diets for pediatric cancer survivors and families

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study examines feasibility, acceptability, and effects of an optimal defaults grocery shopping intervention on dietary quality, energy intake, and grocery costs for families with a pediatric cancer survivor. Families shop for two weeks, then are randomized to receive either weekly recipe packets with nutrition guidance or a similar set plus additional components, while continuing grocery purchasing remotely. Outcomes include changes in nutritional quality, macronutrient intake, and added sugar, as well as parent/guardian dietary intake. The trial uses real-world grocery shopping and receipt data to assess impact in a home setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Parent (or legal guardian) of child that is a survivor of pediatric cancer (any diagnosis)
* Pediatric patient age: 2 ≤ age \< 17 years old at time of study entry
* Child receiving follow-up care at the Roswell Park Comprehensive Cancer Center. The child should no longer be receiving active cancer directed therapy at time of enrollment. There is no limit to the time post treatment
* Parent is the primary caregiver of the child. This is defined as being the parent/guardian who is the most aware of the child's daily activities (or one of multiple guardians who are equally aware)
* Parent does at least 50% of the grocery shopping for the family
* Can be current online grocery shopper or willing to online grocery shop during the study, meeting these requirements: ≥ 75% of their grocery shopping from 1 of 4 specific grocery stores via Instacart (Wegmans, Aldi, Tops, and/or Walmart)
* Child eats ≥ 3 main meals at home with the participating parent per week
* Family does not have any dietary restrictions that would preclude them from being able to use at least some recipes in the study's recipe bank. Most dietary restrictions and preferences (e.g., vegetarian, vegan, halal, gluten-free, allergies to or preferences to avoid particular specific foods) can be accommodated by our large and diverse recipe bank. Only more severe and extensive restrictions would render a family ineligible, such as not being able to eat foods across multiple major food groups
* No history of eating disorders. This includes no history of eating disorders in the participating child's medical record. Parent will also be asked during the screening process to self-report whether or not they have ever been diagnosed with an eating disorder themself
* Participant is not currently receiving supplemental nutritional support such as nasogastric tube (NG), gastrostomy tube (GT) or parenteral support
* Participant is not actively utilizing a medically-tailored meal program, such as RxDiet
* Parent age: \> 18 years-old - NA (No Limit)
* Parent fluent in English
* Participant (or legal representative) must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

Exclusion Criteria:

* Parent is unwilling or unable to follow protocol requirements
* Not meeting above inclusion criteria

Where it's running

• Roswell Park Comprehensive Cancer Center
  Buffalo, New York, United States Recruiting

Study contacts

• Principal investigator: Kara Kelly, MD — Roswell Park Comprehensive Cancer Center
• Study coordinator: Ask Roswellpark
• Email: ASKROSWELL@Roswellpark.org
• Phone: 800-767-9355

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Chatbot-assisted family history and cancer risk assessment in genetic counseling

  A chatbot program tests whether it can collect medical history and estimate cancer risk for patients starting genetic counseling for hereditary breast cancer and other cancer risks.

  Recruiting Roswell Park Cancer Institute · Buffalo, New York · NCT07887620

• Hot-spot SBRT vs standard SBRT for early-stage NSCLC

  This trial tests whether adding intentional high-dose hot spots to SBRT improves tumor control in people with early-stage non-small cell lung cancer.

  Recruiting Phase 2 Roswell Park Cancer Institute · Buffalo, New York · NCT07718672

• Weight-loss programs to slow kidney cancer progression in small renal masses on active surveillance

  This study tests two weight-loss approaches, daily calorie restriction and 5:2 intermittent fasting, to see if they help people with small kidney tumors on active surveillance lose weight and potentially slow cancer progression.

  Recruiting Roswell Park Cancer Institute · Buffalo, New York · NCT07714018

• GB-5267 for platinum-resistant ovarian, peritoneal, or fallopian tube cancer

  This early-phase trial test GB-5267 in adults with platinum-resistant ovarian cancer to see if it is safe and can help shrink tumors.

  Recruiting Phase 1 Roswell Park Cancer Institute · Buffalo, New York · NCT07489287

• Tobacco and cannabis co-use: how young adults start, escalate, and maintain dual use

  This project sees how 18–30-year-olds who use cannabis weekly start, escalate, and keep using either daily cigarettes or daily nicotine vapes.

  Recruiting Roswell Park Cancer Institute · Buffalo, New York · NCT07439471

• Pain patterns and opioid use in adolescent and young adult sarcoma survivors

  This project tests whether a 3-month smartphone-based daily survey can work for adolescents and young adult sarcoma survivors who have ongoing pain or use opioids.

  Recruiting Roswell Park Cancer Institute · Buffalo, New York · NCT07402577

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.